Literature DB >> 10074547

Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci.

L P Jetté1, C Sinave.   

Abstract

In a context of worldwide emergence of resistance among Streptococcus pneumoniae strains, early detection of strains with decreased susceptibility to beta-lactam antibiotics is important for clinicians. If the 1-microgram oxacillin disk diffusion test is used as described by the National Committee for Clinical Laboratory Standards, no interpretation is available for strains showing zone sizes of </=19 mm, and there is presently no disk diffusion test available for screening cephalosporin resistance. The zones obtained by the diffusion method by using the 1-microgram oxacillin disk were compared with penicillin MICs for 1,116 clinical strains and with ceftriaxone MICs for 695 of these strains. Among the 342 strains with growth up to the 1-microgram oxacillin disk margin, none were susceptible (MIC, </=0.06 microgram/ml), 62 had intermediate resistance (MIC, 0.12 to 1.0 microgram/ml), and 280 were resistant (MIC, >/=2.0 microgram/ml) to penicillin. For ceftriaxone, among 98 strains with no zone of inhibition in response to oxacillin, 68 had intermediate resistance (MIC, 1.0 microgram/ml), and 22 were resistant (MIC, >/=2.0 microgram/ml). To optimize the use of the disk diffusion method, we propose that the absence of a zone of inhibition around the 1-microgram oxacillin disk be regarded as an indicator of nonsusceptibility to penicillin and ceftriaxone and recommend that such strains be reported as nonsusceptible to these antimicrobial agents, pending the results of a MIC quantitation method.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074547      PMCID: PMC88670     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.

Authors:  T R Pacheco; C K Cooper; D J Hardy; R F Betts; W Bonnez
Journal:  Am J Med       Date:  1997-03       Impact factor: 4.965

2.  Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae.

Authors:  G V Doern; A B Brueggemann; G Pierce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

3.  Evolution of extended spectrum cephalosporin resistance in the pneumococcus.

Authors:  H J Koornhof; K P Klugman
Journal:  J Antimicrob Chemother       Date:  1997-06       Impact factor: 5.790

Review 4.  Treatment of bacterial meningitis.

Authors:  V J Quagliarello; W M Scheld
Journal:  N Engl J Med       Date:  1997-03-06       Impact factor: 91.245

5.  Use of ceftizoxime screening for the detection of cephalosporin-resistant pneumococci.

Authors:  G E Schutze; M J Lewno; E O Mason
Journal:  Diagn Microbiol Infect Dis       Date:  1997-03       Impact factor: 2.803

6.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

8.  Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

Authors:  J G Bartlett; R F Breiman; L A Mandell; T M File
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

9.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

Review 10.  Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview.

Authors:  F Baquero
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

View more
  7 in total

1.  Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species.

Authors:  M J Mohammed; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.

Authors:  F C Tenover; M J Mohammed; J Stelling; T O'Brien; R Williams
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.

Authors:  P Sandven
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Streptococcus pneumoniae serogroup 6 clones over two decades.

Authors:  D B Payne; B M Gray
Journal:  Epidemiol Infect       Date:  2014-03-18       Impact factor: 4.434

5.  Prevalence and risk factors of pneumococcal nasopharyngeal carriage in healthy children attending kindergarten, in district of Arsi Zone, South East, Ethiopia.

Authors:  Gizaw Abaye; Hailu Fekadu; Kelili Haji; Desalegn Alemu; Antehun Alemayehu Anjulo; Debela T Yadate
Journal:  BMC Res Notes       Date:  2019-05-07

6.  Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia.

Authors:  Eta E Ashu; Sheikh Jarju; Michel Dione; Grant Mackenzie; Usman N Ikumapayi; Ahmed Manjang; Romuladus Azuine; Martin Antonio
Journal:  BMC Infect Dis       Date:  2016-01-28       Impact factor: 3.090

7.  Antimicrobial resistance in Africa: a systematic review.

Authors:  Birkneh Tilahun Tadesse; Elizabeth A Ashley; Stefano Ongarello; Joshua Havumaki; Miranga Wijegoonewardena; Iveth J González; Sabine Dittrich
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.